Apatinib Monotherapy Versus Apatinib Combined With Camrelizumab for Third-line Treatment of Metastatic Gastric Cancer

Conditions:   Gastric Cancer;   Metastasis Interventions:   Drug: Apatinib Mesylate;   Drug: Camrelizumab Sponsor:   Fudan University Recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials